Daniel Raymond has worked in the field of harm reduction for nearly two decades. His extensive experience spans direct service in syringe access to advocacy for drug user health and hepatitis C treatment access. Currently, Mr. Raymond works in collaboration with a broad range of local, state, and national coalitions and advocacy groups to ensure syringe access expansion, the advancement of viral hepatitis treatments, and the effectiveness of HIV prevention and care programming through sound public health policy. He serves on the steering committee of the National Viral Hepatitis Roundtable and has authored articles and numerous report and resources for a national community of providers. Mr. Raymond is a frequent speaker on issues involving drug user health, policy, harm reduction, and innovations in hepatitis C and HIV prevention and treatment.